ScriptMAP-2015: Financial analysis at your fingertips
August 26, 2014
SCRIPTMAP-2015 provides
information and analysis relating
to the Fifth Community Pharmacy
Agreement and includes the impact
of the changed price disclosure
arrangements that will take effect
from 1 October this year.
A ScriptMAP report, using best
available information and based each
pharmacy’s unique dispensing mix,
provides the clearest available picture
of the impact of the changes that will
occur to PBS pricing and pharmacy
remuneration over the Agreement
period. ScriptMAP-2015 provides
information on:
· Pharmacy remuneration as set
down in the Fifth Community
Pharmacy Agreement, including
applicable indexation of fees
· All applied and announced price
reductions, including those due to
Price Disclosure
· Projected growth in the volume of
prescriptions.
· Projected growth in generic
substitution rates.
· Patent expiries throughout the
five years, and subsequent generic
competition
· Annual indexation of PBS copayments,
which impacts on which
drugs fall below the co-payment level
ScriptMAP-2015 is the best financial
tool available to pharmacies. Guild
Members can order their copy of
ScriptMAP-2015 at the special August
only rate of $49. Visit www.guild.org.
au/scriptmap.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Aug 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Aug 14
